A first of its kind consensus statement released by the Heart Rhythm Society (HRS), developed in collaboration with other medical groups on both sides of the Atlantic, offers detailed guidance for physicians, allied professionals, and others in managing the complex issues they face when patients with pacemakers or implantable cardioverter-defibrillators (ICDs) are nearing the end of life or ask for device deactivation.